Tasneem Bawa-Khalfe1,4
, Ghazi F Altememi4
, Chitra D Mandyam2,4
, Lindsay A Schwarz4
, Douglas C Eikenburg4
and Kelly M Standifer3,4 
1Tasneem Bawa-Khalfe, Research Center for Cardiovascular Diseases, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas-Houston Health Science Center, Houston, TX, USA
2Chitra D. Mandyam, Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA
3Kelly M. Standifer, Ph.D., Dept. Pharmaceutical Sciences, 1110 N. Stonewall, Suite 329, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
4Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX, USA